Quantified LSD Effects on Ego Strength

  • Amedeo S. Marrazzi
  • Richard A. Meisch
  • William L. Pew
  • Thomas G. Bieter


The ego has been characterized by Smith [1] as “a coherent organization of mental forces which arranges the processes of the mind in relation to time and reality,” and ego strength according to Mora [2] is “an empirical measure of the level of integration.” It is from such emphasis on the organizational and integrative aspects of mental health and the disorganizing effects of hallucinogens such as LSD that our proposal to measure ego strength stems.


Biological Psychiatry Synaptic Inhibition Mental Force Lysergic Acid Diethylamide Floor Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smith, J. A.: Psychiatry: Descriptive and Dynamic, Williams & Wilkins Co., Baltimore, 1960.Google Scholar
  2. 2.
    Mora, G.: Recent American psychiatric developments, in Arieti, S. (editor): American Handbook of Psychiatry, Chap. 2, Basic Books, Inc., New York, 1959.Google Scholar
  3. 3.
    Marrazzi, A.S.: Restoration of cerebral homeostasis—Basis of biological treatment, in Rinkel, M. (editor): Biological Treatment of Mental Illness, Chap 11, L.C. Page & Co., New York, 1966, p. 222.Google Scholar
  4. 4.
    Marrazzi, A.S.: Synaptic and behavioral correlates of psychotherapeutic and related drug actions, Ann. N.Y. Acad. Sci. 96: 211, 1962.PubMedCrossRefGoogle Scholar
  5. 5.
    Marrazzi, A.S.: An experimentalist looks at psychiatry, in Wortis, J. (editor): Recent Fdvances in Biological Psychiatry, Plenum Press, New York, 1965, p. 143.Google Scholar
  6. 6.
    Slocombe, A., Hoagland, H. and Tozian, L.S.: Am. J. Physiol. 185: 601, 1956.PubMedGoogle Scholar
  7. 7.
    Marrazzi, A.S.: Inhibition as a determinant of synaptic and behavioral patterns. Pavlovian conference on higher nervous activity, Ann. N.Y. Acad. Sci. 92: 998, 1961.Google Scholar
  8. 8.
    Marrazzi, A.S.: Pharmacology of drugs in cerebral palsy, Clinics in Developmental Medicine No. 16, William Heinemann Medical Books Ltd., London, 1964.Google Scholar
  9. 9.
    Hart, E.R., and Marrazzi, A.S.: in Marrazzi, A.S., and Aprison, M. H. (editors): Studies of function in health and disease, Research Hospital Press, Galesburg, 1960, p. 98.Google Scholar
  10. 10.
    Halasz, M. F., and Marrazzi, A.S.: Psychotogen vs. tranquilizer on monkey conditioned approach, Federation Proc. 23: 103, 1964.Google Scholar
  11. 11.
    Chapman, L. F., and Walter, R.D.: Actions of lysergic acid diethylamide on averaged human cortical evoked responses to light flash, in Wortis, J. (editor): Recent Advances in Biological Psychiatry, Plenum Press, New York, 1965, p. 23.Google Scholar
  12. 12.
    Hoch, P.: inCholden, L. (editor): Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry, Grune & Stratton, New York, 1956.Google Scholar
  13. 13.
    Malitz, S., Wilkens, B., and Escover, H. in West, L. J. (editor): Hallucinations, Grune & Stratton, New York, 1962.Google Scholar
  14. 14.
    Marrazzi, A.S. Pharmacodynamics of hallucination, in West, L. J. (editor): Hallucinations, Crune & Stratton, New York, 1962, p. 36.Google Scholar
  15. 15.
    Marrazzi, A.S., Meisch, R.A., and Schiele, B.C.: Cerebral integration and its assessment by drugs, Proc. International College of Neuropsychopharmacology, V International Congress, Washington, D.C., 1966.Google Scholar
  16. 16.
    Marrazzi, A.S., Meisch, R.A., and Sines, L. K.: Effect of hallucinogens and other inhibitors on experimental perceptual aberration, Pharmacologist, 1966, p. 210.Google Scholar
  17. 17.
    Marrazzi, A.S.: The influence of the experimental laboratory on psychiatry towards the turn of the century, in Hoch, Paul H., and Zubin, Joseph (editors): Symposium on the Future of Psychiatry, American Psychopathological Assoc., Crune & Stratton, New York, 1962, p. 19.Google Scholar
  18. 18.
    Halasz, M. F., and Marrazzi, A.S.: Releasing effects of LSD25 on differential conditioning in cats, Federation Proc. 25: 261, 1966.Google Scholar
  19. 19.
    Tanaka, K., and Marrazzi, A.S.: Primate cerebral synaptic inhibition by drugs, Proc. Soc. Exptl. Biol. Med. 120: 669, 1965.Google Scholar

Copyright information

© Plenum Press 1967

Authors and Affiliations

  • Amedeo S. Marrazzi
  • Richard A. Meisch
  • William L. Pew
  • Thomas G. Bieter

There are no affiliations available

Personalised recommendations